[HTML][HTML] New generation of drug delivery systems based on ginsenoside Rh2-, Lysine-and Arginine-treated highly porous graphene for improving anticancer activity
In this study, Rh2–treated graphene oxide (GO-Rh2), lysine-treated highly porous graphene
(Gr-Lys), arginine-treated Gr (Gr-Arg), Rh2–treated Gr-Lys (Gr-Lys-Rh2) and Rh2–treated Gr …
(Gr-Lys), arginine-treated Gr (Gr-Arg), Rh2–treated Gr-Lys (Gr-Lys-Rh2) and Rh2–treated Gr …
Evaluation of toxicity of functionalized graphene oxide with ginsenoside Rh2, lysine and arginine on blood cancer cells (K562), red blood cells, blood coagulation and …
H Zare-Zardini, A Taheri-Kafrani, M Ordooei… - Journal of the Taiwan …, 2018 - Elsevier
In this study, blood-and cardio-toxicity of Rh2–treated graphene oxide (GO-Rh2), lysine-
treated graphene oxide (GO-Lys), arginine-treated GO (GO-Arg), Rh2–treated GO-Lys (GO …
treated graphene oxide (GO-Lys), arginine-treated GO (GO-Arg), Rh2–treated GO-Lys (GO …
Functionalized graphene oxides for drug loading, release and delivery of poorly water soluble anticancer drug: A comparative study
In this work, the modification of graphene oxides (GOs) have been done with hydrophilic and
biodegradable polymer, polyvinylpyrrolidone (PVP) and other excipient β− cyclodextrin (β …
biodegradable polymer, polyvinylpyrrolidone (PVP) and other excipient β− cyclodextrin (β …
Screening of anti-cancer activity of reduced graphene oxide biogenically synthesized against human breast cancer MCF-7 cell lines
Components derived from herbal plants have received great attention in curing several
diseases including cancer. In this present study, the sonication method was employed to …
diseases including cancer. In this present study, the sonication method was employed to …
Apoptosis inducing ability of silver decorated highly reduced graphene oxide nanocomposites in A549 lung cancer
Recently, graphene and graphene-based materials have been increasingly used for various
biological applications due to their extraordinary physicochemical properties. Here, we …
biological applications due to their extraordinary physicochemical properties. Here, we …
Reduced graphene oxide for selective administration of rutin toward the cancer cell therapy
ZM Mohammedsaleh, FM Saleh - Journal of Drug Delivery Science and …, 2023 - Elsevier
The usage of nanomaterials in drug delivery for cancer therapy has been paid significant
attention in recent years. Graphene oxide (GO) is an innovative drug-delivery carbon-based …
attention in recent years. Graphene oxide (GO) is an innovative drug-delivery carbon-based …
[HTML][HTML] Investigating the anticancer and anti-angiogenic effects of graphene oxide nanoparticles containing 6-gingerol modified with chitosan and folate
AHA Al-Janabi, N Hayati Roodbari… - Cancer …, 2023 - Springer
Objective The use of nanocarriers to improve the targeting of treatment plays a key role in
the treatment of many diseases, including cancer. This study was carried out to synthesize …
the treatment of many diseases, including cancer. This study was carried out to synthesize …
Unveiling the anticancer and antibiofilm potential of catechin overlaid reduced graphene oxide/zinc oxide nanocomposites
N Prakashkumar, RM Asik, T Kavitha… - Journal of Cluster …, 2021 - Springer
In the present study, catechin was successfully grafted in reduced graphene oxide Zinc
oxide (rGO/ZnO) nanocomposite by solvent free hydrothermal method. Absorption spectra at …
oxide (rGO/ZnO) nanocomposite by solvent free hydrothermal method. Absorption spectra at …
[HTML][HTML] Novel graphene oxide/quercetin and graphene oxide/juglone nanostructured platforms as effective drug delivery systems with biomedical applications
In this paper, novel drug delivery systems (DDS) were designed based on graphene oxide
(GO) as nanocarrier, loaded with two natural substances (quercetin (Qu) and juglone (Ju)) at …
(GO) as nanocarrier, loaded with two natural substances (quercetin (Qu) and juglone (Ju)) at …
Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy
J Liu, J Dong, T Zhang, Q Peng - Journal of Controlled Release, 2018 - Elsevier
The continuing increase of cancer morbidity and death rate requires efficient therapeutic
strategies. The traditional chemotherapy usually fails to treat cancer or prolong survival rate …
strategies. The traditional chemotherapy usually fails to treat cancer or prolong survival rate …